Bioinformatics Expansion Heralds Further Growth for Almac
News Dec 03, 2009
Almac has shown significant growth in the last year, with employee numbers growing by 15% in the UK and 10% in the US. For the Diagnostics division, this trend continues through the expansion of the Bioinformatics Department and the subsequent opening of a dedicated bioinformatics facility in Manchester (UK).
Professor Paul Harkin, President and Managing Director of Almac Diagnostics said: “With our commitment to the delivery of personalized medicine, we have extended our bioinformatics group to increase our expertise in companion diagnostic development, pharmacodynamic (PD) biomarkers, disease classification and prognostic markers. Our extended expert bioinformatics capability assists our dedication to the advancement of patient care through translational genomic solutions”
Almac’s Bioinformatics group specialise in gene selection, disease characterisation and classification. Bioinformatics is well recognised as a major bottleneck in genomics and the expansion of the bioinformatics group greatly expands Almac’s capacity and hence reduces this problem.
A video interview on the expansion with Professor Paul Harkin can be viewed at
It's easy to take a lot for granted. Scientists do this when they study stress, the force per unit area on an object. Scientists handle stress mathematically by assuming it to have symmetry, but new supercomputer simulations show that at the atomic level, material stress doesn't behave symmetrically. The findings could help scientists design new materials such as glass or metal that doesn't ice up.READ MORE
In late 2017 DeepMind introduced AlphaZero, a single system that taught itself from scratch how to master the games of chess, shogi (Japanese chess), and Go, beating a world-champion program in each case. Today, they announce the evalutation of AlphaZero, published in the journal Science, that confirms and updates those preliminary results.
7th Plant Genomics and Gene Editing Congress: Europe
Oct 10 - Oct 11, 2019